My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
About Us
Plans & Pricing
IMARA (IMRA)
NASDAQ:IMRA
IMRAIMARA
$4.27
-$0.2 (-4.47%)

IMARA Stock Analysis & Ratings

IMARA Stock Analysis Overview

Smart Score
4
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The IMARA stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

IMRA

IMRA Stock Stats

Previous Close$4.47
Open$4.47
Bid0 x 0
Ask0 x 0
Today’s Range$4.2 - $4.5699
52-Week Range$4.05 - $29.10
Volume288.54K
Average Volume217.38K
Market Cap$112.08M
Beta3.67
P/E Ratio-1.6
EPS-2.60
Earnings DateNov 11, 2021

Company Description

IMARA

Imara Inc is a clinical-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin.
Sector
Healthcare
Industry
Biotechnology
CEO
Rahul D. Ballal
Employees
27
ISIN
US45249V1070
Address
116 Huntington Avenue, Boston, MA, 02116, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

IMRA FAQ

What was IMARA’s price range in the past 12 months?
IMARA lowest stock price was $4.05 and its highest was $29.10 in the past 12 months.
    What is IMARA’s market cap?
    IMARA’s market cap is $112.08M.
      What is IMARA’s price target?
      The average price target for IMARA is $24.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $37.00 ,the lowest forecast is $12.00. The average price target represents 473.77% Increase from the current price of $4.27.
        What do analysts say about IMARA?
        IMARA’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
          When is IMARA’s upcoming earnings report date?
          IMARA’s upcoming earnings report date is Nov 11, 2021 which is in 2 months.
            How were IMARA’s earnings last quarter?
            IMARA released its earnings results on Aug 06, 2021. The company reported -$0.743 earnings per share for the quarter, beating the consensus estimate of -$0.911 by $0.168.
              Is IMARA overvalued?
              According to Wall Street analysts IMARA’s price is currently Undervalued.
                Does IMARA pay dividends?
                IMARA does not currently pay dividends.
                What is IMARA’s EPS estimate?
                IMARA’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does IMARA have?
                IMARA has 26,250,000 shares outstanding.
                  What happened to IMARA’s price movement after its last earnings report?
                  IMARA reported an EPS of -$0.743 in its last earnings report, beating expectations of -$0.911. Following the earnings report the stock price went up 0.34%.
                    Which hedge fund is a major shareholder of IMARA?
                    Among the largest hedge funds holding IMARA’s share is RA Capital Management. It holds IMARA’s shares valued at 2M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis